Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



CHASE WILLIAM J Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2023 4 CHASE WILLIAM J (Director) has filed a Form 4 on Intellia Therapeutics, Inc.
Txns: Granted 1,673 shares @ $0
Granted 2,447 options to buy @ $45.2, valued at $110.6k
04/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/28/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/04/2019 4 CHASE WILLIAM J (EVP, Finance & Administration) has filed a Form 4 on AbbVie Inc.
Txns: Paid exercise price by delivering 27,276 shares @ $79.41, valued at $2.2M
02/22/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/14/2018 4 CHASE WILLIAM J (EVP, Finance & Administration) has filed a Form 4 on AbbVie Inc.
Txns: Sold 60,000 shares @ $90, valued at $5.4M
03/02/2018 4 CHASE WILLIAM J (EVP, CFO) has filed a Form 4 on AbbVie Inc.
Txns: Paid exercise price by delivering 28,407 shares @ $118.26, valued at $3.4M
Sold 38,528 shares @ $119.4444, valued at $4.6M
Sold 32,400 shares @ $114.4965, valued at $3.7M
Exercised 13,400 options to buy @ $28.3122, valued at $379.4k
Exercised 19,000 options to buy @ $24.2082, valued at $460k
02/16/2018 4 CHASE WILLIAM J (EVP, CFO) has filed a Form 4 on AbbVie Inc.
Txns: Granted 15,945 shares @ $0
Granted 17,319 shares @ $0
Granted 14,991 shares @ $0
Granted 45,840 options to buy @ $114.36, valued at $5.2M
05/19/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/21/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
12/02/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
03/02/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
02/22/2016 4 CHASE WILLIAM J (EVP, CFO) has filed a Form 4 on AbbVie Inc.
Txns: Granted 95,400 options to buy @ $54.86, valued at $5.2M
03/03/2015 4 CHASE WILLIAM J (EVP, CFO) has filed a Form 4 on AbbVie Inc.
Txns: Paid exercise price by delivering 10,299 shares @ $60.52, valued at $623.3k
Paid exercise price by delivering 8,192 shares @ $60.5, valued at $495.6k
02/23/2015 4 CHASE WILLIAM J (EVP, CFO) has filed a Form 4 on AbbVie Inc.
Txns: Granted 56,040 shares @ $0
Granted 110,770 options to buy @ $58.88, valued at $6.5M
12/22/2014 4 CHASE WILLIAM J (EVP, CFO) has filed a Form 4 on AbbVie Inc.
Txns: Sold 8,495 shares @ $68, valued at $577.7k
Exercised 8,495 options to buy @ $24.0731, valued at $204.5k
03/04/2014 4 CHASE WILLIAM J (EVP, CFO) has filed a Form 4 on AbbVie Inc.
Txns: Paid exercise price by delivering 9,873 shares @ $51.91, valued at $512.5k
Sold 2,448 shares @ $50.191, valued at $122.9k
Sold 1,400 shares @ $50.194, valued at $70.3k
Sold 100 shares @ $51.195, valued at $5.1k
02/24/2014 4 CHASE WILLIAM J (EVP, CFO) has filed a Form 4 on AbbVie Inc.
Txns: Granted 53,770 shares @ $0
Granted 92,740 options to buy @ $51.42, valued at $4.8M
12/20/2013 4 CHASE WILLIAM J (EVP, CFO) has filed a Form 4 on AbbVie Inc.
Txns: Paid exercise price by delivering 6,149 shares @ $54.32, valued at $334k
Exercised 963 options to buy @ $28.9667, valued at $27.9k
Exercised 1,620 options to buy @ $34.4889, valued at $55.9k
Exercised 1,591 options to buy @ $35.2421, valued at $56.1k
Exercised 3,438 options to buy @ $35.985, valued at $123.7k
03/04/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
02/19/2013 4 CHASE WILLIAM J (EVP, CFO) has filed a Form 4 on AbbVie Inc.
Txns: Granted 56,700 shares @ $0
Paid exercise price by delivering 2,912 shares @ $37.58, valued at $109.4k
Granted 115,830 options to buy @ $35.88, valued at $4.2M

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy